|
1
|
Liu Z, Xing WG, Zhang YH, Zhang Q, Long
XS, Zhang GY, Wu H and Jiang Y: Study on the epidemiology and HCV
genotype distribution of HIV/HCV co-infection among HIV infected
blood donors in China. Zhonghua Gan Zang Bing Za Zhi. 14:464–465.
2006.(In Chinese). PubMed/NCBI
|
|
2
|
Rekha RD, Amali AA, Her GM, Yeh YH, Gong
HY, Hu SY, Lin GH and Wu JL: Thioacetamide accelerates
steatohepatitis, cirrhosis and HCC by expressing HCV core protein
in transgenic zebrafish Danio rerio. Toxicology. 243:11–22.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Colomino Iborra M, Sancho-Tell Aguilera V
and Haym Berenguer M: Development of hepatocellular carcinoma (HCC)
in peginterferon and ribavirin HCV-infected cirrhotic treated
patients. Rev Esp Enferm Dig. 98:794–795. 2006.PubMed/NCBI
|
|
4
|
Zhang L, Zhang D, Chen W, Zou X and Ling
L: High prevalence of HIV, HCV and tuberculosis and associated risk
behaviours among new entrants of methadone maintenance treatment
clinics in Guangdong Province, China. PLoS One. 8:e769312013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang C, Wu N, Liu J, Ge Q, Huang Y, Ren
Q, Feng Q and He G: HCV subtype characterization among injection
drug users: Implication for a crucial role of Zhenjiang in HCV
transmission in China. PLoS One. 6:e168172011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee SK, Park SO, Joe CO and Kim YS:
Interaction of HCV core protein with 14-3-3epsilon protein releases
Bax to activate apoptosis. Biochem Biophys Res Commun. 352:756–762.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Quan J, Fan XG, Hu GL, Li N and Tan DM:
The influence of HCV core protein and apoptosis on cellular
telomerase activities. Zhonghua Gan Zang Bing Za Zhi.
12:4242004.(In Chinese). PubMed/NCBI
|
|
8
|
Honda A, Hatano M, Kohara M, Arai Y,
Hartatik T, Moriyama T, Imawari M, Koike K, Yokosuka O, Shimotohno
K and Tokuhisa T: HCV-core protein accelerates recovery from the
insensitivity of liver cells to Fas-mediated apoptosis induced by
an injection of anti-Fas antibody in mice. J Hepatol. 33:440–447.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hahn CS, Cho YG, Kang BS, Lester IM and
Hahn YS: The HCV core protein acts as a positive regulator of
fas-mediated apoptosis in a human lymphoblastoid T cell line.
Virology. 276:127–137. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brost S, Zimmermann A, Koschny R, Sykora
J, Stremmel W, Schirmacher P, Walczak H and Ganten TM: Hepatocyte
expression of TRAIL pathway regulators correlates with
histopathological and clinical parameters in chronic HCV infection.
Pathol Res Pract. 210:83–91. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yano Y, Hayashi Y, Nakaji M, Nagano H, Seo
Y, Ninomiya T, Yoon S, Wada A, Hirai M, Kim SR, et al: Different
apoptotic regulation of TRAIL-caspase pathway in HBV- and
HCV-related hepatocellular carcinoma. Int J Mol Med. 11:499–504.
2003.PubMed/NCBI
|
|
12
|
Wawryk-Gawda E, Chylinska-Wrzos P,
Lis-Sochocka M, Chłapek K, Bulak K, Jędrych M and Jodłowska-Jędrych
B: P53 protein in proliferation, repair and apoptosis of cells.
Protoplasma. 251:525–533. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yoshimura M, Ishizawa J, Ruvolo V, Dilip
A, Quintás-Cardama A, McDonnell TJ, Neelapu SS, Kwak LW, Shacham S,
Kauffman M, et al: Induction of p53-mediated transcription and
apoptosis by exportin-1 (XPO1) inhibition in mantle cell lymphoma.
Cancer Sci. 105:795–801. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yuan F, Xie Q, Wu J, Bai Y, Mao B, Dong Y,
Bi W, Ji G, Tao W, Wang Y and Yuan Z: MST1 promotes apoptosis
through regulating Sirt1-dependent p53 deacetylation. J Biol Chem.
286:6940–6945. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Song G, Wang W and Hu T: p53 facilitates
BH3-only BID nuclear export to induce apoptosis in the irrepairable
DNA damage response. Med Hypotheses. 77:850–852. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wiseman A: p53 protein or BID protein
select the route to either apoptosis (programmed cell death) or to
cell cycle arrest opposing carcinogenesis after DNA damage by ROS.
Med Hypotheses. 67:296–299. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fischer B, Coelho D, Dufour P, Bergerat
JP, Denis JM, Gueulette J and Bischoff P: Caspase 8-mediated
cleavage of the pro-apoptotic BCL-2 family member BID in
p53-dependent apoptosis. Biochem Biophys Res Commun. 306:516–522.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu C, Qu A, Han X and Wang Y: HCV core
protein represses the apoptosis and improves the autophagy of human
hepatocytes. Int J Clin Exp Med. 8:15787–15793. 2015.PubMed/NCBI
|
|
19
|
Beyaert R, Vanhaesebroeck B, Declercq W,
Van Lint J, Vandenabele P, Agostinis P, Vandenheede JR and Fiers W:
Casein kinase-1 phosphorylates the p75 tumor necrosis factor
receptor and negatively regulates tumor necrosis factor signaling
for apoptosis. J Biol Chem. 270:23293–23299. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Izeradjene K, Douglas L, Delaney AB and
Houghton JA: Casein kinase I attenuates tumor necrosis
factor-related apoptosis-inducing ligand-induced apoptosis by
regulating the recruitment of fas-associated death domain and
procaspase-8 to the death-inducing signaling complex. Cancer Res.
64:8036–8044. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen L, Li C, Pan Y and Chen J: Regulation
of p53-MDMX interaction by casein kinase 1 alpha. Mol Cell Biol.
25:6509–6520. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gross SD, Loijens JC and Anderson RA: The
casein kinase Ialpha isoform is both physically positioned and
functionally competent to regulate multiple events of mRNA
metabolism. J Cell Sci. 112:2647–2656. 1999.PubMed/NCBI
|
|
23
|
Elyada E, Pribluda A, Goldstein RE,
Morgenstern Y, Brachya G, Cojocaru G, Snir-Alkalay I, Burstain I,
Haffner-Krausz R, Jung S, et al: CKIα ablation highlights a
critical role for p53 in invasiveness control. Nature. 470:409–413.
2011. View Article : Google Scholar : PubMed/NCBI
|
